The success of Viagra initially drove a boom for pharma, nevertheless recent changes present a complicated outlook for investors. Generic alternatives are eating into earnings, and continued patent challenges add https://brendarmem865654.theideasblog.com/41652783/sildenafil-and-big-pharma-a-risky-bet